Topas
is a Germany-based biotechnology company that researches and develops novel drugs for the treatment of autoimmune and inflammatory diseases... Read moreTopas
is a Germany-based biotechnology company that researches and develops novel drugs for the treatment of autoimmune and inflammatory diseases... Read more
News
May 07, 2025
Medthority
Topas: TPM-502 Shows Positive Results
May 06, 2025
GlobalNewswire
Press Release: Topas : Topas Therapeutics' TPM502 Achieves Gluten-specific Tolerance Induction, Positive Safety Profile in Phase 2a Trial in Celiac Disease Patients
May 05, 2025
Endpoints News
Topas: Topas claims success in early test of 'immune tolerance' celiac therapy
Apr 24, 2025
FinanzNachrichten
Topas: Topas Therapeutics Announces Presentation of Phase 2a Data for TPM502 in Celiac Disease at Digestive Disease Week 2025 in San Diego
Mar 17, 2025
FinanzNachrichten
Topas: Topas Therapeutics Publishes Foundational Data Demonstrating Tolerance Induction by its Proprietary Nanoparticle Platform in Frontiers in Immunology
Oct 16, 2024
Pharmabiz
Topas: Topas Therapeutics announces positive results from phase 2a trial of TPM502 in patients with celiac disease
May 25, 2023
FinanzNachrichten
Topas: Topas Therapeutics Initiates Phase 2a Clinical Trial for TPM502 in Celiac Disease; Appoints Chief Business Officer and Chief Operating Officer
May 25, 2023
Benzinga
Topas: Topas Therapeutics Initiates Phase 2a Clinical Trial for TPM502 in Celiac Disease; Appoints Chief Business Officer and Chief Operating Officer
Jul 29, 2021
MarketScreener
Topas: Gimv : Topas Therapeutics announces and extended Series B round with an additional 18 million ( $ 22 million)
Jul 29, 2021
Global University Venturing
Topas: Topas tops up series B - University Venturing: News, Data, and Events - Global University Venturing
Topas Competitors
1
2
3
4
5
6
7
8
9
10